• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在重症 COVID-19 患者中,NK 细胞群体的异常持续时间延长。

Abnormality in the NK-cell population is prolonged in severe COVID-19 patients.

机构信息

Division of Gastroenterology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

Division of Infectious Diseases, Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea.

出版信息

J Allergy Clin Immunol. 2021 Oct;148(4):996-1006.e18. doi: 10.1016/j.jaci.2021.07.022. Epub 2021 Jul 31.

DOI:10.1016/j.jaci.2021.07.022
PMID:34339730
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8324384/
Abstract

BACKGROUND

Our understanding of adaptive immune responses in patients with coronavirus disease 2019 (COVID-19) is rapidly evolving, but information on the innate immune responses by natural killer (NK) cells is still insufficient.

OBJECTIVE

We aimed to examine the phenotypic and functional status of NK cells and their changes during the course of mild and severe COVID-19.

METHODS

We performed RNA sequencing and flow cytometric analysis of NK cells from patients with mild and severe COVID-19 at multiple time points in the course of the disease using cryopreserved PBMCs.

RESULTS

In RNA-sequencing analysis, the NK cells exhibited distinctive features compared with healthy donors, with significant enrichment of proinflammatory cytokine-mediated signaling pathways. Intriguingly, we found that the unconventional CD56CD16 NK-cell population expanded in cryopreserved PBMCs from patients with COVID-19 regardless of disease severity, accompanied by decreased NK-cell cytotoxicity. The NK-cell population was rapidly normalized alongside the disappearance of unconventional CD56CD16 NK cells and the recovery of NK-cell cytotoxicity in patients with mild COVID-19, but this occurred slowly in patients with severe COVID-19.

CONCLUSIONS

The current longitudinal study provides a deep understanding of the NK-cell biology in COVID-19.

摘要

背景

我们对 2019 冠状病毒病(COVID-19)患者适应性免疫反应的了解正在迅速发展,但关于自然杀伤(NK)细胞固有免疫反应的信息仍然不足。

目的

我们旨在研究 NK 细胞的表型和功能状态及其在轻症和重症 COVID-19 病程中的变化。

方法

我们使用冷冻保存的 PBMC 对轻症和重症 COVID-19 患者在病程中的多个时间点进行了 RNA 测序和 NK 细胞流式细胞分析。

结果

在 RNA 测序分析中,NK 细胞与健康供体相比具有独特的特征,其促炎细胞因子介导的信号通路明显富集。有趣的是,我们发现,无论疾病严重程度如何,COVID-19 患者冷冻保存的 PBMC 中非常规的 CD56CD16 NK 细胞群体都在扩增,同时 NK 细胞的细胞毒性降低。在轻症 COVID-19 患者中,NK 细胞群体随着非常规 CD56CD16 NK 细胞的消失和 NK 细胞细胞毒性的恢复而迅速恢复正常,但在重症 COVID-19 患者中,这一过程较为缓慢。

结论

本纵向研究深入了解了 COVID-19 中的 NK 细胞生物学。

相似文献

1
Abnormality in the NK-cell population is prolonged in severe COVID-19 patients.在重症 COVID-19 患者中,NK 细胞群体的异常持续时间延长。
J Allergy Clin Immunol. 2021 Oct;148(4):996-1006.e18. doi: 10.1016/j.jaci.2021.07.022. Epub 2021 Jul 31.
2
Expansion of CD56CD16 NK Cell Subset and Increased Inhibitory KIRs in Hospitalized COVID-19 Patients.住院 COVID-19 患者中 CD56CD16 NK 细胞亚群扩增和抑制性 KIR 增加。
Viruses. 2021 Dec 28;14(1):46. doi: 10.3390/v14010046.
3
The early expansion of anergic NKG2A/CD56/CD16 natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantation.耗竭型 NKG2A/CD56/CD16 自然杀伤细胞的早期扩增是单倍体造血干细胞移植治疗的靶点。
Haematologica. 2018 Aug;103(8):1390-1402. doi: 10.3324/haematol.2017.186619. Epub 2018 Apr 26.
4
A New Hope for CD56CD16 NK Cells as Unconventional Cytotoxic Mediators: An Adaptation to Chronic Diseases.CD56CD16自然杀伤细胞作为非常规细胞毒性介质的新希望:对慢性疾病的适应性
Front Cell Infect Microbiol. 2020 Apr 21;10:162. doi: 10.3389/fcimb.2020.00162. eCollection 2020.
5
CD56 CD16 Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-α.CD56 CD16 自然杀伤细胞表型分析在接受癌症疫苗和干扰素-α治疗的黑色素瘤患者中的应用。
Front Immunol. 2019 Jan 29;10:14. doi: 10.3389/fimmu.2019.00014. eCollection 2019.
6
Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases.无症状、轻症和重症 SARS-CoV-2 感染者的固有和适应性免疫反应不同。
Front Immunol. 2020 Dec 16;11:610300. doi: 10.3389/fimmu.2020.610300. eCollection 2020.
7
Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells.COVID-19 中 TGFβ 的过早反应限制了 NK 细胞的抗病毒功能。
Nature. 2021 Dec;600(7888):295-301. doi: 10.1038/s41586-021-04142-6. Epub 2021 Oct 25.
8
Elevated Exhaustion Levels of NK and CD8 T Cells as Indicators for Progression and Prognosis of COVID-19 Disease.NK 和 CD8 T 细胞衰竭水平升高可作为 COVID-19 疾病进展和预后的指标。
Front Immunol. 2020 Oct 14;11:580237. doi: 10.3389/fimmu.2020.580237. eCollection 2020.
9
ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.在慢性疲劳综合征/肌痛性脑脊髓炎患者的CD56dimCD16+和CD56brightCD16dim/-自然杀伤细胞中受损的ERK1/2、MEK1/2和p38下游信号分子。
J Transl Med. 2016 Apr 21;14:97. doi: 10.1186/s12967-016-0859-z.
10
Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19.早期 IFN-α 特征和持续功能障碍是严重 COVID-19 中 NK 细胞的显著特征。
Immunity. 2021 Nov 9;54(11):2650-2669.e14. doi: 10.1016/j.immuni.2021.09.002. Epub 2021 Sep 4.

引用本文的文献

1
Difference in Lymphocyte Subset Counts According to Disease Severity and SARS-CoV-2 Variants of Hospitalized COVID-19 Patients in Korea.韩国住院COVID-19患者淋巴细胞亚群计数根据疾病严重程度和SARS-CoV-2变异株的差异
J Korean Med Sci. 2025 Jul 28;40(29):e172. doi: 10.3346/jkms.2025.40.e172.
2
Dysregulated type I/III interferon system in circulation from patients with anti-MDA5-positive dermatomyositis.抗MDA5阳性皮肌炎患者循环中I/III型干扰素系统失调。
Sci Rep. 2025 Jul 15;15(1):25537. doi: 10.1038/s41598-025-10895-1.
3
Dysregulation of NK cell subsets and phenotypes in COVID-19 patients with comorbid type 2 diabetes.

本文引用的文献

1
Unbiased Screens Show CD8 T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein.非偏向性筛选表明 COVID-19 患者的 CD8 T 细胞识别 SARS-CoV-2 中的共享表位,这些表位主要位于 Spike 蛋白之外。
Immunity. 2020 Nov 17;53(5):1095-1107.e3. doi: 10.1016/j.immuni.2020.10.006. Epub 2020 Oct 20.
2
Reduced numbers of T cells and B cells correlates with persistent SARS-CoV-2 presence in non-severe COVID-19 patients.T 细胞和 B 细胞数量减少与非重症 COVID-19 患者中持续存在 SARS-CoV-2 相关。
Sci Rep. 2020 Oct 19;10(1):17718. doi: 10.1038/s41598-020-73955-8.
3
合并2型糖尿病的COVID-19患者自然杀伤细胞亚群和表型的失调
Clin Sci (Lond). 2025 Jun 23;139(12):683-702. doi: 10.1042/CS20243133.
4
Distinct immunity dynamics of natural killer cells in mild and moderate COVID-19 cases during the Omicron variant phase.奥密克戎变异株流行阶段轻度和中度新冠病例中自然杀伤细胞独特的免疫动力学
Front Immunol. 2025 May 12;16:1594296. doi: 10.3389/fimmu.2025.1594296. eCollection 2025.
5
High-affinity CD16A polymorphism associated with reduced risk ofsevere COVID-19.与严重新型冠状病毒肺炎风险降低相关的高亲和力CD16A基因多态性
JCI Insight. 2025 May 22;10(13). doi: 10.1172/jci.insight.191314. eCollection 2025 Jul 8.
6
From natural defenders to therapeutic warriors: NK cells in HIV immunotherapy.从天然防御者到治疗勇士:HIV免疫疗法中的自然杀伤细胞
Immunotherapy. 2025 Feb;17(2):133-145. doi: 10.1080/1750743X.2025.2460965. Epub 2025 Feb 5.
7
COVID-19 infection and inactivated vaccination: Impacts on clinical and immunological profiles in Chinese children with type 1 diabetes.新型冠状病毒肺炎感染与灭活疫苗接种:对中国1型糖尿病儿童临床和免疫学特征的影响
World J Diabetes. 2024 Dec 15;15(12):2276-2284. doi: 10.4239/wjd.v15.i12.2276.
8
Defects in NK cell immunity of pediatric cancer patients revealed by deep immune profiling.深度免疫分析揭示儿童癌症患者自然杀伤细胞免疫缺陷
iScience. 2024 Aug 28;27(9):110837. doi: 10.1016/j.isci.2024.110837. eCollection 2024 Sep 20.
9
scCross: a deep generative model for unifying single-cell multi-omics with seamless integration, cross-modal generation, and in silico exploration.scCross:一个深度生成模型,用于将单细胞多组学数据进行统一,实现无缝集成、跨模态生成和计算探索。
Genome Biol. 2024 Jul 29;25(1):198. doi: 10.1186/s13059-024-03338-z.
10
Immunophenotype of lymphocytes and real-world outcome of COVID-19 infection in children with hematology and oncology.淋巴细胞免疫表型与儿童血液肿瘤患者 COVID-19 感染的真实世界结局
BMC Cancer. 2024 Apr 27;24(1):538. doi: 10.1186/s12885-024-12262-1.
Impaired natural killer cell counts and cytolytic activity in patients with severe COVID-19.
重症 COVID-19 患者自然杀伤细胞计数和细胞溶解活性受损。
Blood Adv. 2020 Oct 27;4(20):5035-5039. doi: 10.1182/bloodadvances.2020002650.
4
Cryopreservation impairs 3-D migration and cytotoxicity of natural killer cells.冷冻保存会损害自然杀伤细胞的 3-D 迁移和细胞毒性。
Nat Commun. 2020 Oct 16;11(1):5224. doi: 10.1038/s41467-020-19094-0.
5
Unique immunological profile in patients with COVID-19.COVID-19 患者的独特免疫特征。
Cell Mol Immunol. 2021 Mar;18(3):604-612. doi: 10.1038/s41423-020-00557-9. Epub 2020 Oct 15.
6
Hemophagocytic lymphohistiocytosis in a patient with COVID-19 treated with tocilizumab: a case report.托珠单抗治疗新型冠状病毒肺炎患者并发噬血细胞性淋巴组织细胞增生症:一例报告
J Med Case Rep. 2020 Oct 15;14(1):187. doi: 10.1186/s13256-020-02503-9.
7
Assessment of the Hemophagocytic Lymphohistiocytosis HScore in Patients With Coronavirus Disease 2019.评估 COVID-19 患者的噬血细胞性淋巴组织细胞增生症 H 评分。
Clin Infect Dis. 2021 Nov 2;73(9):e3110-e3112. doi: 10.1093/cid/ciaa1463.
8
Natural killer cell immunotypes related to COVID-19 disease severity.与 COVID-19 疾病严重程度相关的自然杀伤细胞免疫表型。
Sci Immunol. 2020 Aug 21;5(50). doi: 10.1126/sciimmunol.abd6832.
9
Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19.COVID-19 和流感的免疫表型分析突出了 I 型干扰素在 COVID-19 重症发展中的作用。
Sci Immunol. 2020 Jul 10;5(49). doi: 10.1126/sciimmunol.abd1554.
10
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.COVID-19 疾病患者和未接触者体内针对 SARS-CoV-2 冠状病毒的 T 细胞反应的靶标。
Cell. 2020 Jun 25;181(7):1489-1501.e15. doi: 10.1016/j.cell.2020.05.015. Epub 2020 May 20.